These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature review. Hsiao PJ; Wu KL; Chen YC; Chen YL; Wang RL; Wu KA; Chan JS; Chiu CC; Huang LY; Shyu HY; Kao YH; Chuu CP Clin Chim Acta; 2022 Apr; 529():42-45. PubMed ID: 35167842 [TBL] [Abstract][Full Text] [Related]
10. Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia. Favaloro EJ Int J Lab Hematol; 2021 Aug; 43(4):559-570. PubMed ID: 34138513 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Treatment of Cerebral Venous Thrombosis. Liberman AL Continuum (Minneap Minn); 2023 Apr; 29(2):519-539. PubMed ID: 37039408 [TBL] [Abstract][Full Text] [Related]
12. Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More. Lippi G; Favaloro EJ Semin Thromb Hemost; 2022 Feb; 48(1):8-14. PubMed ID: 34695859 [TBL] [Abstract][Full Text] [Related]
14. Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination. Lee AYY; Al Moosawi M; Peterson EA; McCracken RK; Wong SKW; Nicolson H; Chan V; Smith T; Wong MP; Lee LJ; Griffiths C; Rahal B; Parkin S; Afra K; Ambler K; Chen LYC; Field TS; Lindsay HC; Lavoie M; Li C; Migneault D; Naus M; Piszczek J; Rahmani P; Sreenivasan G; Wan T; Yee A; Zypchen L; Sweet D Blood Adv; 2022 Jun; 6(11):3315-3320. PubMed ID: 35201292 [TBL] [Abstract][Full Text] [Related]
15. Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis. Ostrowski SR; Søgaard OS; Tolstrup M; Stærke NB; Lundgren J; Østergaard L; Hvas AM Front Immunol; 2021; 12():779453. PubMed ID: 34887867 [TBL] [Abstract][Full Text] [Related]
16. Thrombotic events with or without thrombocytopenia in recipients of adenovirus-based COVID-19 vaccines. Cari L; Naghavi Alhosseini M; Bergamo A; Pacor S; Pierno S; Sava G; Nocentini G Front Cardiovasc Med; 2022; 9():967926. PubMed ID: 36247442 [TBL] [Abstract][Full Text] [Related]
17. Cerebral Venous Sinus Thrombosis, Pulmonary Embolism, and Thrombocytopenia After COVID-19 Vaccination in a Taiwanese Man: A Case Report and Literature Review. Lin W; Ko CA; Sung YF; Chen YC; Lee JT; Lin YQ; Lin YK Front Neurol; 2021; 12():738329. PubMed ID: 34630307 [No Abstract] [Full Text] [Related]
18. Brain venography performance following the pause of Ad.26.COV2.S COVID-19 vaccine administration. Long CV; Clemente JD; Singh S; Strong D; Rhoten JB; Prasad T; Asimos AW J Thromb Thrombolysis; 2022 Feb; 53(2):359-362. PubMed ID: 34739662 [TBL] [Abstract][Full Text] [Related]
19. Cerebral Venous Thrombosis in Patients With Heparin-Induced Thrombocytopenia a Systematic Review. Aguiar de Sousa D; Romoli M; Sánchez Van Kammen M; Heldner MR; Zini A; Coutinho JM; Arnold M; Ferro JM Stroke; 2022 Jun; 53(6):1892-1903. PubMed ID: 35240862 [TBL] [Abstract][Full Text] [Related]
20. Increment of D-dimer Associated with Immune Thrombotic Thrombocytopenia in ChAdOx1 nCoV-19 Vaccinated Individuals. Ornelas-Aguirre JM; Gómez-Alcalá AV; Ramírez-Leyva DH Arch Med Res; 2022 Jun; 53(4):341-351. PubMed ID: 35534335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]